Rise Advisors, LLC Nektar Therapeutics Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Rise Advisors, LLC holds 49 shares of NKTR stock, worth $1,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49Holding current value
$1,214% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
160Shares Held
122MCall Options Held
1.18MPut Options Held
64.6K-
Black Rock Inc. New York, NY15.2MShares$376 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$305 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.79MShares$193 Million0.24% of portfolio
-
Acadian Asset Management LLC Boston, MA7.3MShares$181 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$165 Million0.1% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.65B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...